Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

June 30, 2007

Conditions
Primary InsomniaSleep Initiation and Maintenance Disorders
Interventions
DRUG

eszopiclone 3 mg qHS

BEHAVIORAL

General cognitive/behavioral interventions for insomnia

Trial Locations (1)

15213

Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
collaborator

American Academy of Sleep Medicine

OTHER

collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00167375 - Testing the Nocturnal Sleep Latency Profile in Primary Insomnia | Biotech Hunter | Biotech Hunter